These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12270311)

  • 1. Epitope analysis of the HLA class I specific antibodies: a useful tool for the detection of the acceptable mismatches for highly sensitized patients.
    Papassavas AC; Stavropoulos-Giokas C; Boletis J; Iniotaki-Theodoraki A; Ioannou S; Stravoskoufi P; Kostakis A
    Transplant Proc; 2002 Sep; 34(6):2053-5. PubMed ID: 12270311
    [No Abstract]   [Full Text] [Related]  

  • 2. Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients.
    Papassavas AC; Stavropoulos-Giokas C; Boletis J; Ioannou S; Iniotaki-Theodoraki A; Kostakis A
    Eur J Immunogenet; 2002 Oct; 29(5):401-7. PubMed ID: 12358849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation.
    Laundy GJ; Bradley BA
    Transplantation; 1995 Apr; 59(8):1207-13. PubMed ID: 7537397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First report on the antibody verification of MICA epitopes recorded in the HLA epitope registry.
    Duquesnoy RJ; Mostecki J; Marrari M; da Silva AS; da Mata Sousa LC; do Monte SJ
    Int J Immunogenet; 2014 Oct; 41(5):370-7. PubMed ID: 25053277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of acceptable HLA mismatches in highly sensitized patients by soluble HLA class I ELISA inhibition.
    Koelman CA; van Beelen E; Witvliet MD; Doxiadis II; Claas FH
    Transplantation; 2000 Feb; 69(4):656-60. PubMed ID: 10708125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope analysis of HLA class I donor specific antibodies in sensitized renal transplant recipients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Kostakis A; Stavropoulos-Giokas C
    Transplantation; 2000 Jul; 70(2):323-7. PubMed ID: 10933158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation.
    Laux G; Mytilineos J; Opelz G
    Transplantation; 2004 Mar; 77(6):902-7. PubMed ID: 15077035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to private and public HLA class I epitopes in platelet recipients.
    Zimmermann R; Wittmann G; Zingsem J; Blasczyk R; Weisbach V; Eckstein R
    Transfusion; 1999 Jul; 39(7):772-80. PubMed ID: 10413287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
    Papassavas AC; Barnardo MC; Bunce M; Welsh KI
    Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry.
    Duquesnoy RJ; Marrari M; Mulder A; Sousa LC; da Silva AS; do Monte SJ
    Tissue Antigens; 2014 Jun; 83(6):391-400. PubMed ID: 24828056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping and definition of HLA class I and II serologic epitopes using an unbiased reverse engineering strategy.
    Yamamoto F; Wang L; Chang CJ; Tyan DB
    Hum Immunol; 2019 Sep; 80(9):668-702. PubMed ID: 31122739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA matching at the epitope level: the way to go.
    Duquesnoy RJ
    Clin Transpl; 2013; ():441-51. PubMed ID: 25095540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
    El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A; Lias M; Conger N
    Clin Transpl; 2009; ():295-321. PubMed ID: 20524293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA epitope based matching for transplantation.
    Duquesnoy RJ
    Transpl Immunol; 2014 Jun; 31(1):1-6. PubMed ID: 24769079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.